Copyright
©The Author(s) 2017.
World J Diabetes. Jun 15, 2017; 8(6): 286-296
Published online Jun 15, 2017. doi: 10.4239/wjd.v8.i6.286
Published online Jun 15, 2017. doi: 10.4239/wjd.v8.i6.286
Figure 1 Recruitment of participants with type 1 diabetes from the parent Pittsburgh Epidemiology of Diabetes Complications Study into the ancillary neurocognitive study.
EDC: Epidemiology of Diabetes Complications.
Figure 2 Numbers of participants with type 1 diabetes in the ancillary neurocognitive study (n = 108) who reported using lipid lowering and antihypertensive medications from parent study baseline (1986-1988) through time of cognitive assessment (2010-2012).
- Citation: Nunley KA, Orchard TJ, Ryan CM, Miller R, Costacou T, Rosano C. Statin use and cognitive function in middle-aged adults with type 1 diabetes. World J Diabetes 2017; 8(6): 286-296
- URL: https://www.wjgnet.com/1948-9358/full/v8/i6/286.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i6.286